CHEK1 and cancer: Similar effects have been reported in various cancer cell lines of different origin, including ovarian, melanoma, neuroblastoma, leukemia and lymphoma cells, suggesting that combined Chk1/Wee1 inhibition may be a promising approach for cancer treatment [17–22].